No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The amount of purchased research and development assets that are acquired in a business combination and/or licensing arrangement that have no alternative future use and are therefore written off in the period of acquisition.
No authoritative reference available.
The PERCENT effect of a one-percentage-point decrease in the assumed health care cost trend rates on the accumulated postretirement benefit obligation for health care benefits. (For purposes of this disclosure, all other assumptions shall be held constant, and the effects shall be measured based on the substantive plan that is the basis for the accounting.)
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
------------------------------------------
Definition: This item represents the fair value of securities in an unrealized gain position which are categorized neither as held-to-maturity nor trading securities.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Reconciliation of income tax expense (benefit) applying the US federal statutory rate to income (loss) before income taxes to reported income tax expense.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element may be used to capture the complete disclosure pertaining to an entity's basic and diluted earnings per share.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The estimated measure of the MINIMUM percentage amount by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. 0
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Label: Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions
Element ID: us-gaap_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions
Balance Type: na
Data Type: PERCENTAGE
Period Type: instant
---------------------------------------------------------------------
Definition: Disclosure regarding factors used to determine that the impairment of securities not categorized as either held-to-maturity securities or trading securities (hence equal to available for sale securities) where cost exceeds fair value is not an other than temporary impairment. This item contains disclosure of the number of investment positions in the available-for-sale investments determined to be temporarily impaired.
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 03-1
-Paragraph 21
-Subparagraph b(3)
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS115-1/124-1
-Paragraph 17
-Subparagraph b(3)
No authoritative reference available.
Represents contributions to our employee benefit trust, which provides a source of funds to assist us in meeting our obligations under various employee benefit plans.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Disclosure of components of a share-based compensation plan, particularly a rollforward of the units attributable to the plan.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities - Asset Disposals
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Components of Deferred Tax Assets and Liabilities.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The accumulated amount of amortization of a major finite-lived intangible asset class or an adjustment to an indefinite-lived asset. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Number of states prusuant to a particular litigation or loss contingency.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
In addition to other changes to plan assets, the amount of increase or decrease in plan assets attributed to foreign currency changes. The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation whose functional currency is not the reporting currency.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Period of time remaining before a particular Taxing Authority examination reaches conclusion.
No authoritative reference available.
Describes numeric details within an entity's accounting policy for its pension and other postretirement benefit plans. This disclosure may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.
No authoritative reference available.
The amount of purchased research and development assets that are acquired in an in-licensing arrangement and have no alternative future use and are therefore written off in the period of acquisition.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Carrying amount at the balance sheet date of borrowings from a bank, not elsewhere enumerated in the taxonomy, with a maturity within one year (or within one operating cycle if longer) from the date of borrowing. Also includes short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Sum of the gross carrying amounts before accumulated amortization (if applicable) as of the balance sheet date of all intangible assets. The aggregate gross carrying amount (including any previously recognized impairment charges) of a major intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.
No authoritative reference available.
This element may be used to capture the entire disclosure for an employer that sponsors one or more defined benefit pension plans or one or more other defined benefit postretirement plans, of certain information, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans and activity of Level 3 values.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
If aggregate disclosures are presented, the aggregate PROJECTED benefit obligation for plans with benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities - Unremitted Earnings
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Cost of sales, operating expenses, and other-net
No authoritative reference available.
Definition: Composition of total revenue recognized from all transactions, includgin collaboration activity.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The average number of shares issued and outstanding that are used in calculating diluted EPS, determined based on the timing of issuance of shares in the period, before adjustments for stock options and other incremental shares.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The life of the related operating or tax credit carryforwards
No authoritative reference available.
The total weighted average fair value as of grant dates pertaining to a stock option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares, other instruments, or cash in accordance with the terms of the arrangement.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Composition of current and deferred income tax expense.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The PERCENT effect of a one-percentage-point increase in the assumed health care cost trend rates on the aggregate of the service and interest cost components of net periodic postretirement health care benefit costs. (For purposes of this disclosure, all other assumptions shall be held constant, and the effects shall be measured based on the substantive plan that is the basis for the accounting.)
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Research and development assets that are acquired in a business combination and/or licensing arrangement that have no alternative future use and are therefore written off in the period of acquisition, net of tax
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Asset impairment, restructuring, and other special charges, including product liability and legal settlements.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Earnings (loss) per share - basic and diluted
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Amount of collateral that secures the borrowings under the credit facility.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Other assets and liabilities, net, acquired in a business combination, not otherwise allocated.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element may be used to capture the entire disclosure for an employer that sponsors one or more defined benefit pension plans or one or more other defined benefit postretirement plans, of certain information, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.
No authoritative reference available.
This element represents the adjustment of acquiree's tax rate to acquirer's tax rate.
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities - Debt
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The MINIMUM risk-free interest rate assumption that is used in valuing an option on its own shares.
No authoritative reference available.
Goodwill and other intangibles - net
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Gains and other income producing transactions as well as other losses and other expenses that result in no cash inflows or outflows in the period in which they occur, but increase net income and thus are subtracted (removed) when calculating net cash flow from operating activities using the indirect method. This element is used when there is not a more specific and appropriate element.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Describes numeric details within an entity's accounting policy for its pension and other postretirement benefit plans. This disclosure may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.
No authoritative reference available.
The MAXIMUM risk-free interest rate assumption that is used in valuing an option on its own shares.
No authoritative reference available.
If aggregate disclosures are presented, the aggregate fair value of plan assets for pension plans with PROJECTED accumulated benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Percentage description of US defined benefit and other postretirement plan assets as compared to the total global investment balance
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The estimated measure of the MAXIMUM percentage amount by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. 0
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Amount of unremitted earnings in a foreign investment.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The PERCENT effect of a one-percentage-point increase in the assumed health care cost trend rates on the accumulated postretirement benefit obligation for health care benefits. (For purposes of this disclosure, all other assumptions shall be held constant, and the effects shall be measured based on the substantive plan that is the basis for the accounting.)
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
In addition to other changes to plan assets, the amount of increase or decrease in plan assets attributed to foreign currency changes. The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation whose functional currency is not the reporting currency.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities - Inventories
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Definition: Income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants for each period an income statement is presented.
No authoritative reference available.
This element represents the increase of amortization expense of the acquiree.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents the adjustment to interest expense for pro forma presentation.
No authoritative reference available.
The number of claimants in a given litigation or loss contingency
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The gross amount of increases in unrecognized tax benefits resulting from foreign currency translation.
No authoritative reference available.
The direction and pattern of change in the assumed trend rate(s) starting after one year from the current statement of financial position date.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The portion of the noncash component of income tax expense for the period including the net change in the entity's deferred tax assets and liabilities, due to the implementation of the U.S. health care reform.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The PERCENT effect of a one-percentage- point decrease in the assumed health care cost trend rates on the aggregate of the service and interest cost components of net periodic postretirement health care benefit costs. (For purposes of this disclosure, all other assumptions shall be held constant, and the effects shall be measured based on the substantive plan that is the basis for the accounting.)
No authoritative reference available.
The number of plantiffs pursuant to particular litigation or loss contingency.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Description of rights and obligations under the collaborative arrangements - percent share in various revenues and costs.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The minimum life of the related operating or tax credit carryforward.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities - Sale of Intangible Assets
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Shareholders' Equity, Including Treasury Shares. Also includes noncontrolling interest. Balance is prior to deduction of common stock in treasury.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The aggregate sum of gross carrying value of a major intangible asset class, less accumulated amortization and any impairment or other charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Fair value adjustment to carrying value of long term debt to arrive at total fair value.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The maximum life of the related operating or tax credit carryforward.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Description of fluctuations in other assets and other liabilties not disclosed elsewhere.
No authoritative reference available.
Common stock held in trust (Rabbi Trust).
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The number of shares expected to be issued in a future reporting period under the plan.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Disclosure of amortizable and unamortizable intangibles assets, in total and by major class, including the gross carrying amount and accumulated amortization, if applicable. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Percent contribution of most significant geographic areas that contribute to consolidated income (loss) before income taxes.
No authoritative reference available.
The amount of the expected change to cash payments for tax as a result of anticipated change to unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The amount of the expected change to income tax expense as a result of anticipated change to unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents the reduction of the amortization of the acquiree's deferred income.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Represents contributions in SHARES to our employee benefit trust, which provides a source of funds to assist us in meeting our obligations under various employee benefit plans.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Label: Collaborative Arrangement, Rights and Obligations
Element ID: us-gaap_CollaborativeArrangementRightsAndObligations
Balance Type: na
Data Type: MONETARY
Period Type: duration
---------------------------------------------------------------------
Definition: Description of rights and obligations under the collaborative arrangements.
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-1
-Paragraph 21
-Subparagraph b
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Number of lawsuits in a particular litigation or loss contingency.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Definition: Description of a business combination (or series of individually immaterial business combinations) OR OTHER ACQUISITION (e.g. license or asset) completed during the period, including background, timing, and recognized assets and liabilities. This element may be used as a single block of text to encapsulate the entire disclosure (including data and tables) regarding business combinations, including leverage buyout transactions (as applicable).
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Label: Collaborative Arrangement, Nature and Purpose
Element ID: us-gaap_CollaborativeArrangementNatureAndPurpose
Balance Type: na
Data Type: MONETARY
Period Type: duration
---------------------------------------------------------------------
Definition: Description of nature and purpose of collaborative arrangements.
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-1
-Paragraph 21
-Subparagraph a
No authoritative reference available.
Components of other comprehensive income (loss) including, but not limited to, Fx currency translation gains/losses, unrealized net gains/losses on securities, defined benefit pension and retiree health benefit plans, and effective portion of cash flow hedges.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
20 year annualized rate of return on US defined beenfit pension plans and retiree health benefit plans
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Label: Treasury Stock Acquired, Repurchase Authorization
Element ID: us-gaap_TreasuryStockAcquiredRepurchaseAuthorization
Balance Type: na
Data Type: MONETARY
Period Type: duration
---------------------------------------------------------------------
Definition: Description of share repurchase program authorized by an entity's Board of Directors. Include also the allocation of amounts paid to purchase treasury stock.
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 1
-Section B
-Paragraph 11A
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The amount of the total purchase prices allocated to purchased research and development assets that are acquired in a business combination that have no alternative future use and are therefore written off in the period of acquisition.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element may be used to capture the entire disclosure for an employer that sponsors one or more defined benefit pension plans or one or more other defined benefit postretirement plans, of certain information, separately for pension plans and other postretirement benefit plans including the entity's amounts recognized in other comprehensive income.
No authoritative reference available.
Label: Description of Derivative Activity Volume
Element ID: us-gaap_DescriptionOfDerivativeActivityVolume
Balance Type: na
Data Type: PERCENT
Period Type: duration
---------------------------------------------------------------------
Definition: Information that would enable users to understand the volume of the entity's derivative activity.
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44
-Subparagraph 2
No authoritative reference available.
Descriptive information regarding the employer's best estimate, as soon as it can be reasonably determined, of DISCRETIONARY contributions expected to be paid to the plan during the next fiscal year beginning after the date of the latest statement of financial position.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The number of claims in a particular litigation or loss contingency.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Target allocation percentage of investments in growth investments to total plan assets presented on a weighted-average basis as of the measurement date of the latest statement of financial position. The growth investment allocation encompasses U.S. and international public equity securities, hedge funds, and private equity-like investments.
No authoritative reference available.
The direct charge to income tax expense associated with the imposition of tax on the prescription drug subsidy of the company's retiree health plan as part of U.S. health care reform law change.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Sales rebates and discounts
No authoritative reference available.
Acquired in-process research and development, portion attributable to other compounds
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities - Asset Purchases
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element may be used to capture the entire disclosure for an employer that sponsors one or more defined benefit pension plans or one or more other defined benefit postretirement plans, of certain information, separately for pension plans and other postretirement benefit plans including the entity's benefit payments, which reflect expected future service.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The tax effect as of the balance sheet date of the amount of future tax deductions arising from capital losses in excess of statutory limitations in historical filings, and which can only be utilized if sufficient tax-basis income is generated in future periods (or carried back to prior periods) and providing tax laws continue to allow such utilization.
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities - Contingencies
No authoritative reference available.
Component of Deferred Tax Assets/Liabilities -- Intercompany Profit in Inventories
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The cumulative amount of future tax effects arising from the unused tax credit carryforward and carrybacks that cannot be utilized on the tax return during a year that may be carried forward to reduce taxable income or taxes payable in a future year; a tax credit carryforward and carryback is the amount by which tax credits available for utilization exceed statutory limitations.
No authoritative reference available.
This element may be used to capture the entire disclosure for an employer that sponsors one or more defined benefit pension plans or one or more other defined benefit postretirement plans, of certain information, separately for pension plans and other postretirement benefit plans including the entity's weighted average assumptions.
No authoritative reference available.
Net marketing investigation charges accrued (paid)
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Net Employee Stock Ownership Plan activity within shareholders' equity.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.